Ani Pharmaceuticals (ANIP) Treasury Shares (2013 - 2026)

Ani Pharmaceuticals (ANIP) has 13 years of Treasury Shares data on file, last reported at $53.0 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 70.74% year-over-year to $53.0 million; the trailing twelve-month figure through Mar 2026 stood at $53.0 million (up 70.74% YoY), and the FY2025 full-year result was $33.2 million, up 58.03% from the prior year.
• Treasury Shares advanced to $53.0 million in Q1 2026, from $33.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.4 million in Q1 2023 to a low of $25000.0 in Q1 2024.
• A 5-year average of $689397.5 and a median of $613972.0 in 2025 frame the typical range for Treasury Shares.
• Peak annual rise in Treasury Shares reached 256.82% in 2025, while the deepest fall reached 58.03% in 2025.
• Tracing ANIP's Treasury Shares over 5 years: stood at $5.1 million in 2022, then jumped by 97.9% to $10.1 million in 2023, then surged by 108.71% to $21.0 million in 2024, then soared by 58.03% to $33.2 million in 2025, then jumped by 59.42% to $53.0 million in 2026.
• Business Quant data shows ANIP's Treasury Shares at $53.0 million in Q1 2026, $33.2 million in Q4 2025, and $32.6 million in Q3 2025.